28620 articles – 22133 references  [version française]

hal-00591498, version 1

Tumor necrosis factor is not associated with intestinal ischemia/reperfusion-induced lung inflammation.

Alexandre Learth Soares, Fernando Rodrigues Coelho 1, Rodrigo Guabiraba 1, Mamdouh Kamal 1, B Boris Vargaftig, Lily Li, Jian Li 2, Wothan Tavares-De-Lima, Bernhard Ryffel 1

Shock 34, 3 (2010) 306-313

Abstract: Intestinal ischemia-reperfusion (I/R) injury may cause acute systemic and lung inflammation. Here, we revisited the role of TNF-alpha in an intestinal I/R model in mice, showing that this cytokine is not required for the local and remote inflammatory response upon intestinal I/R injury using neutralizing TNF-alpha antibodies and TNF ligand-deficient mice. We demonstrate increased neutrophil recruitment in the lung as assessed by myeloperoxidase activity and augmented IL-6, granulocyte colony-stimulating factor, and KC levels, whereas TNF-alpha levels in serum were not increased and only minimally elevated in intestine and lung upon intestinal I/R injury. Importantly, TNF-alpha antibody neutralization neither diminished neutrophil recruitment nor any of the cytokines and chemokines evaluated. In addition, the inflammatory response was not abrogated in TNF and TNF receptors 1 and 2-deficient mice. However, in view of the damage on the intestinal barrier upon intestinal I/R with systemic bacterial translocation, we asked whether Toll-like receptor (TLR) activation is driving the inflammatory response. In fact, the inflammatory lung response is dramatically reduced in TLR2/4-deficient mice, confirming an important role of TLR receptor signaling causing the inflammatory lung response. In conclusion, endogenous TNF-alpha is not or minimally elevated and plays no role as a mediator for the inflammatory response upon ischemic tissue injury. By contrast, TLR2/4 signaling induces an orchestrated cytokine/chemokine response leading to local and remote pulmonary inflammation, and therefore disruption of TLR signaling may represent an alternative therapeutic target.

  • 1:  Immunologie et embryologie moléculaires (IEM)
  • CNRS : UMR6218 – Université d'Orléans
  • 2:  TRIO (INRIA Lorraine - LORIA)
  • INRIA – CNRS : UMR7503 – Université Henri Poincaré - Nancy I – Université Nancy II – Institut National Polytechnique de Lorraine (INPL)
  • Domain : Life Sciences/Immunology
 
  • hal-00591498, version 1
  • oai:hal.archives-ouvertes.fr:hal-00591498
  • From: 
  • Submitted on: Monday, 9 May 2011 14:32:54
  • Updated on: Monday, 7 November 2011 11:30:59